Sensus Healthcare anticipates significant revenue from FDA agreements in H2 2025
Q4 2024 Management View Joe Sardano, Chairman and CEO, highlighted the company’s strong business momentum in 2024, driven by record sales of SRT-100 systems and the expansion of the Fair Deal ...
Kratom debate intensifies as availability raises concerns in Redding
Kratom, a plant from Southeast Asia, has been a subject of controversy in the United States since its introduction after the ...
US FDA recalls broccoli from stores due to contamination and risk of death: Here's all about it
The U.S. FDA has issued a high-risk recall for broccoli sold at Walmart due to potential Listeria monocytogenes contamination ...